Maravai LifeSciences Holdings, Inc. Stockholders' Equity Attributable to Noncontrolling Interest
Maravai LifeSciences Holdings, Inc. (MRVI) had Stockholders' Equity Attributable to Noncontrolling Interest of $150.97 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:MinorityInterest · last filed 2026-08-07
- 2026-06-30: Stockholders' Equity Attributable to Noncontrolling Interest $150.97M.
- 2026-03-31: Stockholders' Equity Attributable to Noncontrolling Interest $157.52M.
- 2025-12-31: Stockholders' Equity Attributable to Noncontrolling Interest $160.33M.
- 2025-09-30: Stockholders' Equity Attributable to Noncontrolling Interest $186.42M.
| Period end | Stockholders' Equity Attributable to Noncontrolling Interest | Stockholders' Equity Attributable to Noncontrolling Interest as first filed |
|---|---|---|
| 2026-06-30 | $150.97M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $157.52M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $160.33M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $186.42M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $202.12M 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $229.66M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $251.92M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $267.80M 10-K · filed 2025-03-18 | $267.99M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $337.76M 10-K · filed 2025-03-18 | $339.48M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $366.73M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $373.13M 10-K · filed 2025-03-18 | |
| 2023-09-30 | $372.99M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $377.07M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $379.12M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $360.02M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $337.91M 10-Q · filed 2022-11-04 | |
| 2022-06-30 | $317.20M 10-Q · filed 2022-08-05 | |
| 2022-03-31 | $271.74M 10-Q · filed 2022-05-06 | |
| 2021-12-31 | $229.86M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $152.80M 10-Q · filed 2022-11-04 | $150.98M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $141.57M 10-Q · filed 2022-08-05 | $139.22M 10-Q · filed 2021-08-11 |
| 2021-03-31 | $99.69M 10-Q · filed 2022-05-06 | $97.14M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $66.23M 10-K · filed 2022-03-01 |